CL2008001855A1 - Compuestos ciclicos condensados derivados del boro; composicion farmaceutica; y uso en el tratamiento y/o prevencion de una enfermedad infecciosa. - Google Patents
Compuestos ciclicos condensados derivados del boro; composicion farmaceutica; y uso en el tratamiento y/o prevencion de una enfermedad infecciosa.Info
- Publication number
- CL2008001855A1 CL2008001855A1 CL2008001855A CL2008001855A CL2008001855A1 CL 2008001855 A1 CL2008001855 A1 CL 2008001855A1 CL 2008001855 A CL2008001855 A CL 2008001855A CL 2008001855 A CL2008001855 A CL 2008001855A CL 2008001855 A1 CL2008001855 A1 CL 2008001855A1
- Authority
- CL
- Chile
- Prior art keywords
- boron
- prevention
- treatment
- pharmaceutical composition
- infectious disease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Compuestos ciclicos condensados derivados del boro; composición farmacéutica; y uso en el tratamiento y/o prevención de una enfermedad infecciosa.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94529407P | 2007-06-20 | 2007-06-20 | |
US4117808P | 2008-03-31 | 2008-03-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2008001855A1 true CL2008001855A1 (es) | 2009-05-29 |
Family
ID=40156702
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2008001855A CL2008001855A1 (es) | 2007-06-20 | 2008-06-20 | Compuestos ciclicos condensados derivados del boro; composicion farmaceutica; y uso en el tratamiento y/o prevencion de una enfermedad infecciosa. |
Country Status (29)
Country | Link |
---|---|
US (4) | US7816344B2 (es) |
EP (1) | EP2164331B1 (es) |
JP (3) | JP5530923B2 (es) |
KR (3) | KR20150100945A (es) |
CN (2) | CN101772302B (es) |
AR (1) | AR067105A1 (es) |
AU (1) | AU2008265630B2 (es) |
BR (1) | BRPI0813450B8 (es) |
CA (1) | CA2692135C (es) |
CL (1) | CL2008001855A1 (es) |
CO (1) | CO6251209A2 (es) |
CR (1) | CR11224A (es) |
DK (1) | DK2164331T3 (es) |
DO (1) | DOP2009000281A (es) |
EA (1) | EA020530B1 (es) |
ES (1) | ES2655299T3 (es) |
IL (1) | IL202379A (es) |
JO (1) | JO3396B1 (es) |
MA (1) | MA31675B1 (es) |
MX (1) | MX347688B (es) |
MY (1) | MY162692A (es) |
NO (1) | NO2164331T3 (es) |
NZ (1) | NZ582706A (es) |
PE (1) | PE20090840A1 (es) |
SG (1) | SG182219A1 (es) |
TW (1) | TW200911822A (es) |
UY (1) | UY31171A1 (es) |
WO (1) | WO2008157726A1 (es) |
ZA (2) | ZA200909003B (es) |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ560448A (en) | 2005-02-16 | 2009-08-28 | Anacor Pharmaceuticals Inc | Boron-containing small molecules |
RU2008131324A (ru) | 2005-12-30 | 2010-02-10 | Анакор Фармасьютикалз, Инк. (Us) | Борсодержащие малые молекулы |
DK1988779T5 (en) | 2006-02-16 | 2016-10-10 | Anacor Pharmaceuticals Inc | SMALL boron MOLECULES AS ANTI-INFLAMMATORY AGENTS |
BRPI0711155A2 (pt) | 2006-05-02 | 2011-08-23 | Anacor Pharmaceuticals Inc | terapêuticos contendo boro resistentes hidroliticamente e métodos de uso |
JO3396B1 (ar) * | 2007-06-20 | 2019-10-20 | Anacor Pharmaceuticals Inc | جزيئات صغيرة تحتوي على البورون |
RU2547441C2 (ru) | 2008-03-06 | 2015-04-10 | Анакор Фармасьютикалз, Инк. | Борсодержащие малые молекулы в качестве противовоспалительных агентов |
US20100256092A1 (en) * | 2008-05-12 | 2010-10-07 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
EP2348863A4 (en) | 2008-09-04 | 2012-03-07 | Anacor Pharmaceuticals Inc | BORN SMALL MOLECULES |
WO2010028005A1 (en) | 2008-09-04 | 2010-03-11 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
US9493489B2 (en) | 2008-10-15 | 2016-11-15 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as anti-protozoal agents |
MA32977B1 (fr) * | 2008-12-17 | 2012-01-02 | Anacor Pharmaceuticals Inc | Formes polymorphiques du (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo(c(1,2)oxaborol-1-ol |
WO2010132833A1 (en) * | 2009-05-14 | 2010-11-18 | The Regents Of The University Of Michigan | Streptococcus vaccine compositions and methods of using the same |
EP2458995A1 (en) | 2009-07-28 | 2012-06-06 | Anacor Pharmaceuticals, Inc. | Trisubstituted boron-containing molecules |
WO2011019616A1 (en) | 2009-08-14 | 2011-02-17 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as antiprotozoal agents |
AP4039A (en) * | 2009-08-14 | 2017-02-28 | Daitao Chen | Boron-containing small molecules as antiprotozoal agents |
WO2011019612A1 (en) | 2009-08-14 | 2011-02-17 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as antiprotozoal agents |
MX2012002031A (es) * | 2009-08-19 | 2012-07-04 | Anacor Pharmaceuticals Inc | Moleculas pequeñas que contienen boro como agentes antiprotozoarios. |
US20110124597A1 (en) * | 2009-09-25 | 2011-05-26 | Anacor Pharmaceuticals, Inc. | Boron containing small molecules |
US8979820B2 (en) | 2009-10-09 | 2015-03-17 | Cynthia S. Bailey | Method and apparatus for improving the appearance of nails affected by onychomycosis through the topical application of an aqueous solution containing boric acid and camphor or other terpenes |
US9346834B2 (en) | 2009-10-20 | 2016-05-24 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as antiprotozoal agents |
US8461134B2 (en) | 2009-11-11 | 2013-06-11 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
US8716478B2 (en) | 2010-01-27 | 2014-05-06 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
US8623911B2 (en) | 2010-03-19 | 2014-01-07 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as anti-protozoal agent |
SG184268A1 (en) * | 2010-04-07 | 2012-10-30 | Glaxosmithkline Llc | Process for preparing benzoxaboroles |
SG10201507032YA (en) * | 2010-09-07 | 2015-10-29 | Anacor Pharmaceuticals Inc | Benzoxaborole derivatives for treating bacterial infections |
WO2013025975A1 (en) * | 2011-08-17 | 2013-02-21 | Glaxosmithkline Llc | Combination treatments for hepatitis c |
WO2013049424A1 (en) | 2011-09-28 | 2013-04-04 | Wisconsin Alumni Research Foundation | Catalytic conversion of cellulose to fuels and chemicals using boronic acids |
AR088669A1 (es) | 2011-11-21 | 2014-06-25 | Lilly Co Eli | Derivados de dihidrodibenzo[c][1,2]oxaborol y dihidroisoxazol utiles para el control de ectoparasitos |
AR088668A1 (es) | 2011-11-21 | 2014-06-25 | Lilly Co Eli | Moleculas pequeñas que contienen boro |
KR20140114380A (ko) * | 2011-12-22 | 2014-09-26 | 미큐알엑스 파마슈티칼스, 인크. | 항미생물 요법용 트리시클릭 붕소 화합물 |
WO2013154759A1 (en) | 2012-04-14 | 2013-10-17 | Anacor Pharmaceuticals, Inc. | Benzoxaborole compounds and uses thereof |
US11039617B2 (en) | 2013-01-30 | 2021-06-22 | Agrofresh Inc. | Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness |
US10070649B2 (en) | 2013-01-30 | 2018-09-11 | Agrofresh Inc. | Volatile applications against pathogens |
US9585396B2 (en) | 2013-01-30 | 2017-03-07 | Agrofresh Inc. | Volatile applications against pathogens |
RU2595157C1 (ru) | 2013-01-30 | 2016-08-20 | Агрофреш Инк. | Применение бензоксаборолов в качестве антимикробных агентов для обработки мясных продуктов, растений или частей растений |
US8669207B1 (en) | 2013-01-30 | 2014-03-11 | Dow Agrosciences, Llc. | Compounds and compositions |
US9446131B2 (en) | 2013-01-31 | 2016-09-20 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US9433680B2 (en) | 2013-01-31 | 2016-09-06 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US9452173B2 (en) | 2013-01-31 | 2016-09-27 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US8778365B1 (en) | 2013-01-31 | 2014-07-15 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
WO2014121124A1 (en) | 2013-02-01 | 2014-08-07 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as antiprotozoal agents |
AU2014202928B1 (en) * | 2013-06-05 | 2014-09-11 | Agrofresh Inc. | Compounds and compositions |
KR101636431B1 (ko) * | 2013-07-30 | 2016-07-05 | 동아에스티 주식회사 | 트리사이클릭 벤즈옥사보롤 화합물, 이의 제조방법 및 용도 |
AU2014305792C1 (en) * | 2013-08-09 | 2018-07-05 | Anacor Pharmaceuticals, LLC. | Tricyclic benzoxaborole compounds and uses thereof |
EA038093B1 (ru) * | 2013-12-20 | 2021-07-05 | Глаксосмитклайн Интеллекчуал Проперти (№2) Лимитед | Способ лечения заболевания, вызванного инфекцией комплекса mycobacterium tuberculosis, с использованием (s)-(3-хлор-7,8-дигидро-2h-1,6,9-триокса-9a-борабензо[cd]азулен-2-ил)метанамина или его фармацевтически приемлемой соли |
CN106029673B (zh) * | 2014-02-17 | 2018-12-21 | 先正达参股股份有限公司 | 杀微生物活性的苯并氧杂硼 |
WO2016001834A1 (en) | 2014-07-01 | 2016-01-07 | Daiichi Sankyo Company, Limited | Tricyclic benzoxaboroles as antibacterial agents |
WO2016069955A1 (en) * | 2014-10-29 | 2016-05-06 | Wisconsin Alumni Research Foundation | Boronic acid inhibitors of hiv protease |
MA41494B1 (fr) | 2015-02-12 | 2020-10-28 | Glaxosmithkline Ip No 2 Ltd | Composés benzoxaborole substitués en position 4 et utilisations associées |
BR112017021478B1 (pt) | 2015-04-09 | 2022-04-19 | The Penn State Research Foundation | Composição antifúngica sinérgica que contém benzoxaborol |
CA3014757C (en) * | 2015-08-06 | 2020-01-14 | The Penn State Research Foundation | Benzoxaborole-containing coating resistant to cellulose-supportable fungus |
EP3423065B1 (en) | 2016-03-02 | 2021-07-21 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
US10874679B2 (en) | 2016-03-02 | 2020-12-29 | Bill & Melinda Gates Foundation | Boron-containing small molecules |
EP3423159A4 (en) | 2016-03-02 | 2019-11-06 | Anacor Pharmaceuticals, Inc. | BORN SMALL MOLECULES |
TW201735792A (zh) | 2016-03-07 | 2017-10-16 | 農業保鮮股份有限公司 | 使用苯并氧雜硼雜環戊烯化合物和防腐氣體作為作物的抗微生物劑之協同方法 |
CN109153688A (zh) | 2016-05-12 | 2019-01-04 | 安纳考尔医药公司 | 氧杂硼杂环戊烷酯类及其用途 |
WO2018160845A1 (en) | 2017-03-01 | 2018-09-07 | Anacor Pharmaceuticals, Inc. | Novel oxaborole analogs and uses thereof |
CN107090000B (zh) * | 2017-04-27 | 2019-07-12 | 上海交通大学 | 一种苯并硼唑7位脂肪酸的衍生物及其制备与用途 |
CA3067372A1 (en) * | 2017-06-13 | 2018-12-20 | Veterinary Diagnostics Institute, Inc. | System and procedure for stabilizing, storing and recovering blood samples |
JP2021505660A (ja) * | 2017-11-30 | 2021-02-18 | ボラゲン,インコーポレーテッド | ベンゾキサボロール化合物およびその配合物 |
CA3120974A1 (en) * | 2017-11-30 | 2019-06-06 | Boragen, Inc. | Combinatorial compositions of benzoxaboroles and biologic agents |
WO2020041200A1 (en) | 2018-08-18 | 2020-02-27 | Boragen Inc. | Solid forms of substituted benzoxaborole and compositions thereof |
WO2020051575A1 (en) * | 2018-09-07 | 2020-03-12 | Boragen, Inc. | Boron containing compounds and their uses |
US11058695B2 (en) * | 2019-11-08 | 2021-07-13 | Myongji University Industry And Academia Cooperation Foundation | Inhibitor of carbapenem-hydrolyzing class D beta-lactamases |
WO2022043936A1 (en) | 2020-08-31 | 2022-03-03 | Pfizer Inc. | Methods of protecting rna |
WO2023246841A1 (en) * | 2022-06-23 | 2023-12-28 | Shanghai Micurx Pharmaceutical Co., Ltd. | Methods and uses of boron compounds in the treatment of nontuberculous mycobacterium infections and pharmaceutical compositions for treatment of same |
WO2023246842A1 (en) * | 2022-06-23 | 2023-12-28 | Shanghai Micurx Pharmaceutical Co., Ltd. | Prodrugs of boron compounds and their use in treating bacterial infections |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2260336A (en) * | 1939-10-16 | 1941-10-28 | Dow Chemical Co | Method of preparation of organic borates |
GB1396904A (en) * | 1972-08-11 | 1975-06-11 | Ici Ltd | Method for the control of micro-organisms |
US5962498A (en) * | 1986-06-11 | 1999-10-05 | Procyon Pharmaceuticals, Inc. | Protein kinase C modulators. C. indolactam structural-types with anti-inflammatory activity |
US4919934A (en) | 1989-03-02 | 1990-04-24 | Richardson-Vicks Inc. | Cosmetic sticks |
US5594151A (en) * | 1994-01-28 | 1997-01-14 | Prolinx, Inc. | Phenylboronic acid complexing reagents derived from aminosalicylic acid |
GB9411587D0 (en) * | 1994-06-09 | 1994-08-03 | Zeneca Ltd | Compound, composition and use |
US6083903A (en) * | 1994-10-28 | 2000-07-04 | Leukosite, Inc. | Boronic ester and acid compounds, synthesis and uses |
US5831046A (en) * | 1996-08-05 | 1998-11-03 | Prolinx, Incorporated | Boronic acid-contaning nucleic acid monomers |
US6306628B1 (en) * | 1999-08-25 | 2001-10-23 | Ambergen, Incorporated | Methods for the detection, analysis and isolation of Nascent proteins |
AU7995300A (en) * | 1999-10-05 | 2001-05-10 | Bethesda Pharmaceuticals, Inc. | Dithiolane derivatives |
CA2415938A1 (en) * | 2000-07-14 | 2002-01-24 | Zycos Inc. | Alpha-msh related compounds and methods of use |
US6537733B2 (en) * | 2001-02-23 | 2003-03-25 | Applied Materials, Inc. | Method of depositing low dielectric constant silicon carbide layers |
GB0117645D0 (en) * | 2001-07-19 | 2001-09-12 | Isis Innovation | Therapeutic stratergies for prevention and treatment of alzheimers disease |
DE10143979A1 (de) | 2001-09-07 | 2003-03-27 | Clariant Gmbh | Verfahren zur Herstellung von Bisallylboranen und nicht-aromatischen Boronsäuren |
JPWO2003033002A1 (ja) * | 2001-10-11 | 2005-02-03 | 御子柴 克彦 | 細胞内カルシウム濃度上昇抑制剤 |
CN1325504C (zh) | 2002-01-10 | 2007-07-11 | 宾夕法尼亚州研究基金会 | 制备二芳基硼酸烷基酯和络合的二芳基硼酸的方法 |
BR0311419A (pt) * | 2002-05-28 | 2005-04-05 | Dimensional Pharm Inc | Amidinas de tiofeno suas composições e métodos de tratamento de doenças e condições mediadas por complemento |
CA2529792A1 (en) * | 2003-06-16 | 2005-02-17 | Anacor Pharmaceuticals, Inc. | Hydrolytically-resistant boron-containing therapeutics and methods of use |
DK1755661T3 (da) * | 2004-05-12 | 2014-06-16 | Brigham & Womens Hospital | Gelsolin til anvendelse til behandling af infektioner |
NZ560448A (en) * | 2005-02-16 | 2009-08-28 | Anacor Pharmaceuticals Inc | Boron-containing small molecules |
RU2008131324A (ru) * | 2005-12-30 | 2010-02-10 | Анакор Фармасьютикалз, Инк. (Us) | Борсодержащие малые молекулы |
DK1988779T5 (en) | 2006-02-16 | 2016-10-10 | Anacor Pharmaceuticals Inc | SMALL boron MOLECULES AS ANTI-INFLAMMATORY AGENTS |
US20070286822A1 (en) * | 2006-06-12 | 2007-12-13 | Anacor Pharmaceuticals Inc. | Compounds for the Treatment of Periodontal Disease |
CA2654449A1 (en) | 2006-06-12 | 2007-12-21 | Anacor Pharmaceuticals, Inc. | Compounds for the treatment of periodontal disease |
DE102006038471A1 (de) | 2006-08-17 | 2008-04-10 | Wala-Heilmittel Gmbh | Platanencreme, Verfahren zu ihrer Herstellung und Verwendung |
JO3396B1 (ar) * | 2007-06-20 | 2019-10-20 | Anacor Pharmaceuticals Inc | جزيئات صغيرة تحتوي على البورون |
US20100256092A1 (en) * | 2008-05-12 | 2010-10-07 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
-
2008
- 2008-06-18 JO JOP/2008/0288A patent/JO3396B1/ar active
- 2008-06-19 SG SG2012045712A patent/SG182219A1/en unknown
- 2008-06-19 DK DK08825921.3T patent/DK2164331T3/da active
- 2008-06-19 BR BRPI0813450A patent/BRPI0813450B8/pt active IP Right Grant
- 2008-06-19 NZ NZ582706A patent/NZ582706A/en unknown
- 2008-06-19 AU AU2008265630A patent/AU2008265630B2/en active Active
- 2008-06-19 KR KR1020157021997A patent/KR20150100945A/ko not_active IP Right Cessation
- 2008-06-19 ES ES08825921.3T patent/ES2655299T3/es active Active
- 2008-06-19 WO PCT/US2008/067550 patent/WO2008157726A1/en active Application Filing
- 2008-06-19 KR KR1020167009966A patent/KR101685656B1/ko active IP Right Grant
- 2008-06-19 CA CA2692135A patent/CA2692135C/en active Active
- 2008-06-19 NO NO08825921A patent/NO2164331T3/no unknown
- 2008-06-19 CN CN200880101464.4A patent/CN101772302B/zh active Active
- 2008-06-19 EA EA200901617A patent/EA020530B1/ru not_active IP Right Cessation
- 2008-06-19 MY MYPI20095460A patent/MY162692A/en unknown
- 2008-06-19 CN CN201410134063.6A patent/CN104017008A/zh active Pending
- 2008-06-19 KR KR1020107001062A patent/KR101578351B1/ko active IP Right Grant
- 2008-06-19 US US12/142,692 patent/US7816344B2/en active Active
- 2008-06-19 EP EP08825921.3A patent/EP2164331B1/en active Active
- 2008-06-19 MX MX2015007480A patent/MX347688B/es unknown
- 2008-06-19 JP JP2010513416A patent/JP5530923B2/ja active Active
- 2008-06-20 UY UY31171A patent/UY31171A1/es unknown
- 2008-06-20 AR ARP080102661A patent/AR067105A1/es active IP Right Grant
- 2008-06-20 PE PE2008001074A patent/PE20090840A1/es not_active Application Discontinuation
- 2008-06-20 TW TW097123257A patent/TW200911822A/zh unknown
- 2008-06-20 CL CL2008001855A patent/CL2008001855A1/es unknown
-
2009
- 2009-11-26 IL IL202379A patent/IL202379A/en active IP Right Grant
- 2009-12-11 DO DO2009000281A patent/DOP2009000281A/es unknown
- 2009-12-17 ZA ZA2009/09003A patent/ZA200909003B/en unknown
- 2009-12-18 CO CO09145296A patent/CO6251209A2/es not_active Application Discontinuation
-
2010
- 2010-01-15 MA MA32517A patent/MA31675B1/fr unknown
- 2010-01-18 CR CR11224A patent/CR11224A/es unknown
- 2010-07-30 US US12/848,051 patent/US8895534B2/en active Active
-
2011
- 2011-06-21 ZA ZA2011/04573A patent/ZA201104573B/en unknown
-
2014
- 2014-04-21 JP JP2014087397A patent/JP2014148531A/ja active Pending
- 2014-11-07 US US14/536,483 patent/US9796735B2/en active Active
-
2015
- 2015-09-24 JP JP2015187239A patent/JP6570391B2/ja active Active
-
2017
- 2017-09-28 US US15/718,422 patent/US10533021B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2008001855A1 (es) | Compuestos ciclicos condensados derivados del boro; composicion farmaceutica; y uso en el tratamiento y/o prevencion de una enfermedad infecciosa. | |
CL2007002327A1 (es) | Compuestos derivados de fenil-imidazol sustituido; composicion farmaceutica; y uso en el tratamiento del vhc. | |
CL2012001405A1 (es) | Compuestos derivados de espiroindolinona-pirrolidinas; proceso de obtención; composicion farmaceutica; y uso en el tratamiento o profilaxis del cancer. | |
CL2008001076A1 (es) | Compuestos derivados de sulfonamida; composicion farmaceutica; y uso en el tratamiento del cancer. | |
CL2008003406A1 (es) | Compuestos derivados de quinolina; composicion farmaceutica que los comprende; y uso en el tratamiento de una infeccion por vih. | |
CL2007000806A1 (es) | Compuestos derivados de heteropentaciclos sustituidos; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento del cancer. | |
CL2012003026A1 (es) | Composicion farmaceutica que comprende pioglitazona y linagliptina; procedimiento de preparacion; uso en el tratamiento de la diabetes tipo 2 o la obesidad. | |
CL2008002540A1 (es) | Compuestos derivados aza-indol-2,3-sustituidos; composicion farmaceutica; y uso ene l tratamiento de una infeccion viral. | |
CL2009000200A1 (es) | Compuestos derivados de 2,7-naftiridinas-1-ona, mediadores de syk; composicion farmaceutica; y uso en el tratamiento de una enfermedad inflamatoria, respiratoria, proliferativa celular o autoinmune. | |
CL2011002787A1 (es) | Compuestos derivados de 1-cianoetilheterociclilcarboxamida sustituidos, inhibidores de dipeptidilpeptidasa i (dppi) o catepsina c; composicion farmaceutica; combinacion faramceutica; y su uso en el tratamiento del asma, la enfermedad obstructiva cronica o la rinitis alergica. | |
CL2012001176A1 (es) | Compuestos derivados de bencimidazol-imidazol, inhibidores del virus de la hepatitis c (hcv); composición farmacéutica que los comprende; combinación farmacéutica; uso en la prevención o tratamiento de infección de hcv. | |
CL2008002369A1 (es) | Compuestos derivados de piridin-3-il-oxipiridin-2-il-amino, inhibidores de alk5; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento del cancer. | |
CL2007002167A1 (es) | Compuestos derivados de indol, antagonistas iap; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de cancer. | |
CL2009000119A1 (es) | Compuestos derivados de amino-bencimidazoles sustituidos; composicion farmaceutica; y su uso en el tratamiento del alzheimer. | |
CL2007003686A1 (es) | Compuestos derivados de indol con anillo unido en las posiciones 4,5; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para tratar una infeccion viral. | |
CL2008001157A1 (es) | Compuestos derivados de quinolina-carboxamida, antagonistas de p2y12; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; composicion de una combinacion de dichos compuestos; y uso del compuesto en el tratamiento de trastornos cardiovasculares, tromboembolismo, infarto agudo al miocardio. | |
CL2008001540A1 (es) | Compuestos derivados de pirrolopiridinas y pirazolopiridinas; composicion farmaceutica; y uso en el tratamiento del cancer. | |
CL2012001080A1 (es) | Dispersión sólida de rifaximina y un portador farmacéuticamente aceptable; composición farmacéutica; uso en el tratarmiento y/o prevención de una infecciíon microbiana que comprende la administración de la dipersión sólida. | |
CL2007002207A1 (es) | Compuestos derivados de sulfonilaminas; composicion farmaceutica; y uso de los compuestos en el tratamiento del glaucoma. | |
CL2008002049A1 (es) | Compuestos derivados de aminoindol macrociclicos; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la hepatitis c. | |
AR077125A1 (es) | Combinaciones farmaceuticas utiles para tratar el vhc | |
CL2011000979A1 (es) | Compuestos derivados ftalazina 1,4-disustituida; composicion farmaceutica; y su uso en el tratamiento del cancer. | |
CL2013003229A1 (es) | Compuestos inhibidores del virus de la hepatitis c (vhc); composicion farmaceutica que los comprende; y uso en el tratamiento de una infeccion por vhc. | |
CL2008002689A1 (es) | Compuestos derivados de heterociclo 1,4 piperidina sustituida; compuestos intermediarios; composicion farmaceutica; proceso de preparacion; y su uso en el tratamiento del alzheimer y esquizofrenia. | |
AR077139A1 (es) | Composiciones farmaceuticas utiles para tratar el vch |